StartupsFinSMEsabout 10 hours ago
Syntax Bio Expands Series A to Over $25M
1 min read
Syntax Bio raised its Series A round to over $25 million. The company focuses on developing programmable cell therapies. The additional funding will support further research and development efforts.
Level
Hype check
Tap to vote and see what everyone thinks.
